Outcomes following preoperative chemoradiation +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Aaron R. Weiss, Yen-Lin Chen, Thomas Scharschmidt, Wei Xue, Zhengya Gao, Jennifer O. Black, Julie Fanburg-Smith, Eduardo Zambrano, Edwin Choy, Jessica L. Davis, Mark Kayton, Lynn Million, Scott H. Okuno, Andrew Ostrenga, R. Lor Randall, Stephanie Terezakis, Rajkumar Venkatramani, Dian Wang, Douglas S. Hawkins, Sheri L. Spunt
Institutions: Maine Medical Center, Massachusetts General Hospital, The Ohio State University, University of Florida, Children's Hospital Colorado, Penn State Health Children's Hospital, Rocky Mountain Hospital for Children, Oregon Health & Science University, Jersey Shore University Medical Center, Stanford Medicine, Stanford University, Mayo Clinic, University of Mississippi, Huntsman Cancer Institute, Masonic Cancer Center, Texas Children's Hospital, Rush University Medical Center, Seattle Children's Hospital, University of Washington, Fred Hutch Cancer Center, Lucile Packard Children's Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4281707382